Stock COGT COGENT BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Cogent Biosciences, Inc.

Equities

COGT

US19240Q2012

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-08 EDT 		5-day change 1st Jan Change
7.6 USD -2.06% Intraday chart for Cogent Biosciences, Inc. +9.67% +29.25%
05-07 Cogent Biosciences Q1 Loss Widens MT
05-07 Cogent Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cogent Biosciences, Inc. Appoints Rachael Easton, VP, Head of Clinical Development
CI
Cogent Biosciences Appoints Evan Kearns as Chief Legal Officer
CI
Insider Trends: Cogent Biosciences Insider Extends 90-Day Selling Trend
MT
Cogent Biosciences Announces Creation of Cogent Research Team
CI
Cogent Biosciences, Inc. Appoints John Robinson as Chief Scientific Officer
CI
Cogent Biosciences, Inc. Appoints Sara Saltzman as Senior Vice President of Regulatory Affairs
CI
Cogent Biosciences Appoints Todd E. Shegog to its Board of Directors
CI
Cogent Biosciences, Inc. Appoints Brad Barnett as Chief Technology Officer
CI
Cogent Biosciences, Inc. Announces Executive Changes
CI
Cogent Biosciences, Inc Announces Executive Changes
CI
Cogent Biosciences, Inc Announces Management Changes
CI
Unum Therapeutics Inc. will Change its Name to Cogent Biosciences, Inc
CI
Unum Therapeutics Inc. Announces Changes to the Board and Appointments to the Committees
CI
Unum Therapeutics Inc. Announces Executive Changes
CI
Unum Therapeutics Inc. Plans to Reduce its Current Workforce; Announces Resignation of Seth Ettenberg as Chief Scientific Officer
CI
Unum Therapeutics Inc. Announces New Appointments to its Board of Directors
CI
Unum Therapeutics Inc. Announces Management Changes
CI
Unum Therapeutics Inc. Announces Management Changes
CI
Unum Therapeutics Inc. Appoints Christiana Stamoulis to the Additional Role of President
CI
Unum Therapeutics Inc. Appoints Karen J. Ferrante and Robert J. Perez to its Board of Directors
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. COGT Stock
  4. News Cogent Biosciences, Inc.
  5. Insiders
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW